University of Arkansas for Medical Sciences (UAMS) College of Medicine Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 485
• Acute Myeloid Leukemia Research 74
• CAR-T cell therapy research 65
• Myeloproliferative Neoplasms: Diagnosis and Treatment 60
• Hematopoietic Stem Cell Transplantation 54
• Viral-associated cancers and disorders 53
• Chronic Lymphocytic Leukemia Research 41
• Lymphoma Diagnosis and Treatment 29
• Chronic Myeloid Leukemia Treatments 23
• Immunotherapy and Immune Responses 18
• Amyloidosis: Diagnosis, Treatment, Outcomes 17
• Bone health and treatments 13

Most cited

1. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

   Science (New York, N.Y.) · 2021 · 792 citations · Yusra Medik

2. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

   Blood · 2025 · 135 citations · Shebli Atrash

3. Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 271 citations · Shebli Atrash

4. Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study.

   The Lancet. Haematology · 2025 · 93 citations · Carolina Schinke

5. Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab.

   The New England journal of medicine · 2026 · 33 citations · Shebli Atrash

6. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 69 citations ·